Meliora Therapeutics is a mechanism-driven, machine learning powered precision oncology company focused on developing next generation small molecule oncology drugs. Established in 2021, Meliora is pioneering a novel approach to connecting targets, mechanisms, and appropriate chemistry to develop a flywheel of high value clinical drugs, leveraging advances in CRISPR, molecular biology, and machine learning based discovery technologies.
